Show simple item record

A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: A real-life experience [Refrakter kronik immün trombositopeni tedavisinde eltrombopagın etkinliğine ilişkin çok merkezli bir çalışma: Gerçek y

dc.contributor.authorÇekdemir, D.
dc.contributor.authorGüvenç, S.
dc.contributor.authorÖzdemirkıran, F.
dc.contributor.authorEser, A.
dc.contributor.authorToptaş, T.
dc.contributor.authorÖzkocaman, V.
dc.contributor.authorŞahin, H.H.
dc.contributor.authorTurak, E.E.
dc.contributor.authorEsen, R.
dc.contributor.authorCömert, M.
dc.contributor.authorSadri, S.
dc.date.accessioned2021-12-21T08:40:57Z
dc.date.available2021-12-21T08:40:57Z
dc.date.issued2019
dc.identifier.issn13007777
dc.identifier.urihttps://doi.org/10.4274/tjh.galenos.2019.2018.0307
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1269
dc.description.abstractObjective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total of 285 chronic ITP patients (18
dc.language.isoEnglish
dc.publisherTurkish Society of Hematology
dc.rightsAll Open Access, Bronze, Green
dc.titleA multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: A real-life experience [Refrakter kronik immün trombositopeni tedavisinde eltrombopagın etkinliğine ilişkin çok merkezli bir çalışma: Gerçek y
dc.typeArticle
dc.relation.journalTurkish Journal of Hematology
dc.identifier.issue4
dc.identifier.startpage230
dc.identifier.endpage237
dc.identifier.volume36
dc.identifier.doi10.4274/tjh.galenos.2019.2018.0307
dc.relation.issue4
dc.relation.volume36


Files in this item

Thumbnail
Name:
A Multi-Center Study on the ...
Size:
270.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record